<DOC>
	<DOCNO>NCT00611130</DOCNO>
	<brief_summary>The objective study demonstrate large proportion vigabatrin-treated subject placebo-treated subject cocaine-free last 2 week treatment .</brief_summary>
	<brief_title>Vigabatrin Treatment Cocaine Dependence</brief_title>
	<detailed_description>Cocaine addiction , serious public health concern associate significant medical , social , economic consequence , difficult treat use traditional psychosocial behavioral therapy . Despite test number different agent cocaine dependency , remain proven pharmacologic treatment cocaine addiction . The addictive property cocaine associate action mesotelencephalic dopamine reward pathways central nervous system ( CNS ) . Cocaine administration increase level dopamine , neurotransmitter associate sensation pleasure reward . Therefore , block cocaine-induced increase dopamine level represent valid pharmaceutical approach treatment cocaine addiction . Another neurotransmitter , gamma-aminobutyric acid ( GABA ) , suppress striatal dopamine release , attenuate cocaine-induced increase extracellular synaptic dopamine level striatum nucleus accumbens animal model drug dependence . Significant elevation brain GABA level may reduce cocaine-stimulated dopamine release dampen sensation pleasure reward . Thus , drug potentiate enhance GABA-ergic transmission candidate treatment cocaine addiction .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Vigabatrin</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Able understand study provide write informed consent . Male female least 18 year age . Meets DSMIV ( Diagnostic Statistical Manual Mental Disorders Fourth Edition ) criteria cocaine dependence primary diagnosis , determine Substance Abuse module SCID ( Structured Clinical Interview DSMIV ) . Provide least one urine sample positive cocaine accord rapid screening test . Seeking treatment cocaine dependence . Have normal visual field . Be generally good health base history , physical examination , electrocardiogram laboratory finding . If female childbearing potential , use acceptable contraceptive method . ( oral contraceptive ( pill ) , IUDs , contraceptive implant skin , contraceptive ring patch injection , diaphragm spermicide , condom spermicide ) . Surgical sterilization tubal ligation hysterectomy acceptable Has current dependence , determine SCID , psychoactive substance cocaine , alcohol , nicotine , marijuana physiologic dependence alcohol require medical detoxification . Has serious medical psychiatric illness and/or clinically significant abnormal laboratory value , judgment Principal Investigator his/her designee would make study participation unsafe , would make treatment compliance difficult put study staff undue risk . Be court mandate obtain treatment . Be enrol opiate substitution treatment program within 2 month randomization . Has ever take vigabatrin past . Is pregnant lactating . Has clinically significant ophthalmologic disease , would preclude safety monitor undergoing treatment ocular disease . Has receive drug know major organ toxicity , include retinotoxicity within 30 day randomization . Is currently participate , enrol another clinical trial within last 30 day . Be anyone , judgment investigator , would expect attend regular study visit complete study protocol , due imminent relocation clinic area , legal difficulty , workrelated problem , transportation , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cocaine</keyword>
	<keyword>Addiction</keyword>
	<keyword>Dependence</keyword>
	<keyword>Treatment</keyword>
</DOC>